We are live on ! Find out more
SBRA icon

Sabra Healthcare REIT

459 hedge funds and large institutions have $4.97B invested in Sabra Healthcare REIT in 2026 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 189 increasing their positions, 130 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

667% more call options, than puts

Call options by funds: $5.28M | Put options by funds: $688K

84% more first-time investments, than exits

New positions opened: 68 | Existing positions closed: 37

45% more repeat investments, than reductions

Existing positions increased: 189 | Existing positions reduced: 130

5% more funds holding

Funds holding: 439459 (+20)

3% more capital invested

Capital invested by funds: $4.84B → $4.97B (+$130M)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

0.04% less ownership

Funds ownership: 102.51%102.48% (-0.04%)

Holders
459
Holders Change
+20
Holders Change %
+4.56%
% of All Funds
5.65%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
68
Increased
189
Reduced
130
Closed
37
Calls
$5.28M
Puts
$688K
Net Calls
+$4.59M
Net Calls Change
+$1.03M
Name Holding Trade Value Shares
Change
Change in
Stake
Allspring Global Investments
276
Allspring Global Investments
North Carolina
$379K +$37.3K +1,892 +11%
NA
277
NewEdge Advisors
Louisiana
$379K +$71.4K +3,627 +23%
I
278
InceptionR
California
$375K -$182K -9,223 -32%
CCIA
279
Cherry Creek Investment Advisors
Colorado
$373K +$2.09K +106 +0.5%
SAM
280
Securian Asset Management
Minnesota
$357K +$8.13K +413 +2%
PA
281
Parallel Advisors
California
$356K -$8.65K -439 -2%
PCM
282
Prelude Capital Management
New York
$342K +$350K +17,780 New
CWS
283
Cypress Wealth Services
California
$338K +$512 +26 +0.1%
Cambridge Investment Research Advisors
284
Cambridge Investment Research Advisors
Iowa
$332K +$54.3K +2,758 +19%
ATC
285
Argent Trust Co
Tennessee
$327K
AIA
286
AssuredPartners Investment Advisors
Florida
$326K +$326K +16,530 New
PWP
287
Principle Wealth Partners
Connecticut
$325K
Acadian Asset Management
288
Acadian Asset Management
Massachusetts
$315K -$618K -31,385 -66%
HIS
289
Harvest Investment Services
Illinois
$308K +$7.15K +363 +2%
HNB
290
Huntington National Bank
Ohio
$307K +$294K +14,915 +1,437%
CFO
291
Callan Family Office
Pennsylvania
$306K +$9.69K +492 +3%
HT
292
Headlands Technologies
Illinois
$300K +$307K +15,581 New
Baird Financial Group
293
Baird Financial Group
Wisconsin
$298K +$305K +15,498 New
CIA
294
Concurrent Investment Advisors
Florida
$297K +$305K +15,461 New
Federated Hermes
295
Federated Hermes
Pennsylvania
$296K +$19.1K +972 +7%
WWM
296
Western Wealth Management
Colorado
$294K +$301K +15,283 New
ATPW
297
Ashton Thomas Private Wealth
Arizona
$291K +$298K +15,116 New
CCM
298
Chilton Capital Management
Texas
$281K +$35.3K +1,794 +14%
SLAM
299
Swiss Life Asset Management
$273K +$60K +3,044 +27%
JSW
300
Journey Strategic Wealth
New Jersey
$273K +$7.49K +380 +3%

SBRA Hedge Fund Activity: Q1 2026 in Review

459 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Sabra Healthcare REIT (SBRA) for Q1 2026, worth a combined $4.97B — up 2.7% from $4.84B a quarter earlier.

Buyers outnumbered sellers: 68 funds opened new SBRA positions and 37 closed out — a net gain of 31 holders — while 189 added to existing stakes and 130 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $110M. The largest seller was APG Asset Management US, cutting an estimated $47.5M.

  • 459 institutional investors held Sabra Healthcare REIT (SBRA) as of Q1 2026, up from 439 in Q4 2025.
  • Funds reported $4.97B of Sabra Healthcare REIT stock for Q1 2026, up 2.7% quarter-over-quarter.
  • 68 funds opened new Sabra Healthcare REIT positions in Q1 2026 and 37 closed out, a net change of +31 holders.
  • The largest Sabra Healthcare REIT buyer in Q1 2026 was JP Morgan Chase, an estimated $110M added.
  • The largest Sabra Healthcare REIT seller in Q1 2026 was APG Asset Management US, an estimated $47.5M sold.

Based on aggregated 13F filings for Q1 2026.